Interactive E-health Database for the Identification of Potential Interactions Among Drugs Prescribed to CKD Patient
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04310501 |
|
Recruitment Status :
Recruiting
First Posted : March 17, 2020
Last Update Posted : November 12, 2020
|
Sponsor:
University of Ioannina
Information provided by (Responsible Party):
Evangelia Ntounousi, University of Ioannina
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The aim of the current project is the development and implementation of an e-health database of drug interactions (drug-drug, drug-food, drug-alcohol and drug-herbal products interaction) to CKD patients in order to achieve a holistic approach to patient care and personalized medicine. The study will be conducted in the University of Ioannina (cooperation between the Department of Nephrology and the Laboratory of Physiology). Data will be collected form 150 CKD patients (Stages 1-5 pre-dialysis, undergoing dialysis, kidney transplantation). Sixty patients will be selected for the pilot study which will include blood and urine tests and specific polymorphism analysis (pharmacogenetic tests). Pilot implementation of the e-health database will be undertaken by health professionals of the Department of Nephrology (University Hospital of Ioannina) to test the system in realistic setting (usability, efficiency and efficacy) in order to make the necessary changes prior to full scale deployment.
| Condition or disease |
|---|
| Renal Insufficiency, Chronic |
| Study Type : | Observational |
| Estimated Enrollment : | 150 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Cross-Sectional |
| Official Title: | Development of an Interactive E-health Database Aimed to Identify Potential Interactions Among Drugs Prescribed to Chronic Kidney Disease (CKD) Patient |
| Actual Study Start Date : | April 23, 2020 |
| Estimated Primary Completion Date : | March 2021 |
| Estimated Study Completion Date : | March 2021 |
Resource links provided by the National Library of Medicine
| Group/Cohort |
|---|
|
CKD Patients
Patients (n=150) with CKD (Stages 1-5 pre-dialysis, undergoing dialysis, kidney transplantation) who fulfil the inclusion criteria from the Nephrology Dept and Renal Transplant Unit of the University Hospital of Ioannina. Sixty patients will be selected for the pilot study which will include blood and urine tests and specific polymorphism analysis (pharmacogenetic tests) |
Primary Outcome Measures :
- E-health database [ Time Frame: 1-12 months until completion of patients recruitment ]E-health database of drug interactions (drug-drug, drug-food, drug-alcohol and drug-herbal products interaction) to CKD patients in order to achieve a holistic approach to patient care and personalized medicine.
Biospecimen Retention: Samples With DNA
Whole blood
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
150 patients with Chronic Kidney Disease (stages 1-5 pre-dialysis, kidney transplantation) from the Nephrology Department of University Hospital of Ioannina
Criteria
Inclusion Criteria:
- Age>18 years
- CKD diagnosis according to KDOQI Guidelines
- absence of active malignancy
- absence of decompensated heart failure New York Heart Association (NYHA) IV
- absence of liver cirrhosis
- patient's consent
Exclusion Criteria:
- Age<18 years
- active malignancy
- decompensated heart failure NYHA IV
- liver cirrhosis
- patient's refusal to participate in the study
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04310501
Contacts
| Contact: Evangelia Ntounousi, PHD | +302651099653 | evangeldou@gmail.com |
Locations
| Greece | |
| University Hospital of Ioannina | Recruiting |
| Ioánnina, Greece, 45110 | |
| Contact: Evangelia Dounousi, PHD +302651099653 evangeldou@gmail.com | |
Sponsors and Collaborators
University of Ioannina
Investigators
| Principal Investigator: | Evangelia Ntounousi, PHD | University of Ioannina |
Publications:
| Responsible Party: | Evangelia Ntounousi, Assistant Professor, University of Ioannina |
| ClinicalTrials.gov Identifier: | NCT04310501 |
| Other Study ID Numbers: |
RESCOMUOI82476 |
| First Posted: | March 17, 2020 Key Record Dates |
| Last Update Posted: | November 12, 2020 |
| Last Verified: | November 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Evangelia Ntounousi, University of Ioannina:
|
Drug Interactions Polymorphism, Genetic Pharmacogenetics Databases, Pharmaceutical |
Additional relevant MeSH terms:
|
Renal Insufficiency Renal Insufficiency, Chronic Kidney Diseases Urologic Diseases |